Venlafaxine Hydrochloride Tablet, Extended Release
Product Images NDC 69367-418

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 69367-418). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Westminster Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Venlafaxine 01)

Chemical structure of venlafaxine hydrochloride, showing its molecular composition including a methoxyphenyl group, cyclohexanol moiety, and dimethylaminoethyl side chain, along with the hydrochloride component.*

FDA Label Image

Principal Display Panel (150 mg Tablet Bottle Label)

Label for Venlafaxine Hydrochloride Extended-release Tablets 150 mg by Westminster Pharmaceuticals. The label includes dosage instructions, storage conditions, quantity of 90 tablets, and a barcode. It specifies the product as Rx only, with handling instructions and a website for medication guides.*

FDA Label Image

Principal Display Panel (225 mg Tablet Bottle Label)

Label for Venlafaxine Hydrochloride Extended-release Tablets 225 mg by Westminster Pharmaceuticals, LLC. Oral extended-release tablets, packaged as 90 tablets. Label includes dosage information, storage instructions, and barcode with NDC 69367-418-09.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.